Recent News

rss

Important Information

from the State Medical Board of Ohio

Upcoming Closure in Honor Martin Luther King Jr. Day

The Medical Board's office will be closed on Monday, January 15, 2018 in honor of Martin Luther King Jr. Day. The office will reopen at 8 A.M. on Tuesday. 

Proposed Physician Assistant Rule Changes - Comment Period Open

You are invited to review proposed rule changes and submit comments. The proposed rules showing the amendments are located here on our website. Comments will be accepted until the close of business on January 18, 2018.

 

The following three rules have been reviewed by the Physician Assistant Policy Committee and the State Medical Board for consistency with current law. This memo sets out the proposed actions resulting from the review.

  • Rule 4730-1-05: Quality assurance system.

  • Rule 4730-2-04: Provisional period of physician-delegated prescriptive authority.

  • Rule 4730-2-05: Certificate to prescribe.

 

Send your comments to: Sallie Debolt, Senior Counsel, State Medical Board of Ohio

Sallie.Debolt@med.ohio.gov

 

December Issue of eNews posted

The December 2017 issue of the Medical Board's eNews has arrived. Here are the highlights:

  • Ohio's Rules for Acute Pain Opioid Prescribing - Phase 2

  • License Renewal Deadline

  • J-1 Visa Waiver Program Application

  • 2018 Medical Board Officers

  • PA Rules Under Review - Comment Period Open

  • January Holiday Closure Dates

Click here for all of the details.

 

Prescription Changes Beginning Tomorrow - 12/29/17

Beginning tomorrow, December 29, 2017, phase 2 of prescribing opioids for acute pain takes effect.

 

ICD-10 Required on Opioid Analgesic Prescriptions 

Prescribers are required to indicate the first four alphanumeric characters of the ICD-10-CM medical diagnosis code (ex. M16.5) on all opioid prescriptions. If your EHR system cannot generate the ICD-10 code automatically, you can simply add the ICD-10 numbers into the comment section on the prescription or write it in manually. 

 

Days’ Supply Required for Controlled Substance and Gabapentin Prescriptions

Changes in Pharmacy Board Rule 4729-5-30, OAC, require prescribers to include the days’ supply (i.e. minimum number of days) that the prescription for a controlled substance or gabapentin should last the patient. 

 

Written, Faxed and Electronic Prescriptions

The Pharmacy Board rule also makes changes to the requirements for written, faxed and electronic prescriptions. Except in limited circumstances, prescribers can no longer transmit prescriptions using a transmission system that converts the prescription into a computer-generated fax or scanned image.

For more information on the exceptions, visit: http://www.pharmacy.ohio.gov/approval

 

See our Prescriber Resources page for a complete reference guide, prescription requirements, video, FAQs and more.

 

Specify Alternate Text

License Renewal Deadline on 1/1/18

Licenses will expire on January 1st for physicians, massage therapists and cosmetic therapists with a last name beginning with “S.” Use the self-serve portal to renew your license at http://bit.ly/2yEw7vE. If you need assistance with your renewal, please send an email to license@med.ohio.gov.

Specify Alternate Text

Upcoming Office Closures

The Medical Board will be closed on the following dates in December and January:

  • December 25

  • January 1 

  • January 15

Our office will reopen at 8 a.m. on the day following each of these closures.

 

Specify Alternate Text

Effective December 29 - Phase 2 of Prescribing Opioids for Acute Pain

Starting on December 29, 2017 prescribers are required to include the ICD-10 code on prescriptions for opioids to treat acute pain. Please confirm that your EMR and/or e-prescribing vendor(s) can support automated placement of the ICD-10 code on prescriptions. If your EMR system is not able to automate the code by December 29, 2017, you can simply add the ICD-10 numbers into the comment section on the prescription or write it in manually. 

See our Prescriber Resources page for a complete reference guide, prescription requirements, video, FAQs and more.

 

 

The November Issue of eNews is Available

The November 2017 issue of the Medical Board's eNews has arrived. Here are the highlights:

  • Prescribing Opioids for Acute Pain Rules - Phase 2 (Effective 12/29/2017)

  • New Board Member

  • Ohio Opioid Technology Challenge

  • Survey Club Emails

  • Acupuncture Services Through Medicaid

  • Upcoming Cosmetic Therapy Exam

  • HealthScene Ohio Magazine, Fall Issue

  • Take Charge Ohio Campaign Launched

  • Monthly Formal Action Reports

Click here for all of the details.

 

Prescribing Opioids for Acute Pain Rules - Phase 2 (Effective December 29, 2017)

Ohio’s rules for prescribing opioids to address acute pain took effect in August 2017. Starting December 29, 2017 prescribers are required to include the ICD-10 code on prescriptions for opioids to treat acute pain. If you have not yet confirmed that your EMR and/or e-prescribing vendor(s) can support automated placement of the ICD-10 code on prescriptions, is it strongly suggested that you contact them immediately. If your EMR system is not able to automate the code by December 29, 2017, you can simply add the ICD-10 numbers into the comment section on the prescription or write it in manually. The State Medical Board has provided information on the new acute prescribing rules over the past four months and will be releasing additional educational information next month about the new rule requirements.

 

State of Ohio Board of Pharmacy Mistakenly Sends OARRS Email

Please be advised that the State of Ohio Board of Pharmacy sent out emails this morning to approximately 7,000 prescribers indicating failure to comply with laws requiring the use of the Ohio Automated Rx Reporting System (OARRS).

The emails were erroneously distributed without the knowledge of the State Medical Board of Ohio, Ohio Board of Nursing or the Ohio State Dental Board and may contain inaccurate information. If you received this morning’s email, please disregard it. You do not need to take any further action at this time. The Pharmacy Board apologizes for this mistake and any concerns it may have caused.